$28.15
0.00 (0%)
Schering-Plough Corp (NYSE:SGP.DL)
CAPS Rating:
The Company discovers, develops, manufactures and markets medical therapies and treatments to enhance human health.
The Company discovers, develops, manufactures and markets medical therapies and treatments to enhance human health.
BATS data provided in real-time. NYSE, NASDAQ and AMEX data delayed 15 minutes.
Real-Time prices provided by BATS. Market data provided by Interactive Data.
Company fundamental data provided by Morningstar. Earnings Estimates and Analyst Ratings provided by Zacks.
SEC Filings and Insider Transactions provided by Edgar Online.
Powered and implemented by Interactive Data Managed Solutions. Terms & Conditions
Recs
All of big pharma has become a real mess, more concerned with marketing and lobbying than with developing good products. This will backfire sooner or later.